|View printer-friendly version|
|September 14, 2005 11:43 a.m.|
|Teva Announces Approval of Leflunomide Tablets|
Jerusalem, Israel, September 14, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Leflunomide Tablets, 10 mg and 20 mg. Shipment of this product will begin immediately.